Product category:
Laboratory and scientific databases
News Release from: Inforsense
Edited by the Laboratorytalk Editorial
Team on 12 April 2006
High-throughput pathway-centric data
analysis
InforSense and GeneGo are integrating their technologies to allow researchers to better probe their data and share their work process across different research domains
InforSense has joined forces with GeneGo, a leading provider of systems biology tools and databases The companies are integrating their technologies to allow researchers to better probe their data and share their work process across different research domains
This article was originally published on Laboratorytalk on 17 Jun 2005 at 8.00am (UK)
Related stories
Selected for information services support
Biogen Idec will use both InforSense KDE and InforSense's integrated TextSense text mining technology to build and deploy tailored decision-support software applications
Five-year plan for cancer genotyping
Agreement covers high-throughput genetics analysis using Grid computing platform for rapid development and publication of applications for cancer research
GeneGo has also joined the InforSense Open Workflow Partner Network.
The integration of GeneGo's unique reference system for curated pathway analysis and InforSense's integrated, interactive workflow-based data mining technology allows researchers to query their data and share their results across the research and development value chain.
In addition to the integration of InforSense KDE and MetaCore, which is already available, the companies are in the process of integrating InforSense KDE with both MetaDrug and MetaBase.
Further reading
Bayer chooses informatics package
InforSense KDE, will provide Bayer with a highly flexible rapid application development platform to optimise its drug discovery decision-making
InforSense expands collaboration with AstraZeneca
Global licence provides access to InforSense integrative analytics technology across all AstraZeneca research and development (R and D) sites
Enabling decision-making, enterprise-wide
Latest InforSense KDE delivers integrative data analysis, visualisation, and software composition to decision-makers; increased productivity gained by quicker and more precise workflow deployment
Customer feedback supports integration of GeneGo's software suite with the proven InforSense workflow technology, as researchers will be enabled to bridge domains such as genomics and metabolomics with high confidence data using a systems biology approach.
In addition, users will be able to annotate pathway data with experimental results and clinical data and thereby better predict patient outcomes.
"The collaboration between InforSense and GeneGo will deliver to thousands of users the needed environment for leveraging high-throughput biology and chemistry data more effectively for better and faster decision-making within the life science industry," said Julie Bryant, vice president of business development of GeneGo.
"InforSense workflows enable life science researchers to compose and execute scientific analyses quickly and easily without programming, sharing both methods and results with co-workers." "MetaCore has grown to become a key component in the research toolbox in the life sciences, particularly within the pharmaceutical industry, and we are pleased to have the opportunity to work with GeneGo," commented Jonathan Sheldon, chief scientific officer, InforSense.
"The integration of pathway analysis with InforSense KDE is a key component of our multidisciplinary analytics platform for Systems Biology." GeneGo develops tools for integration and systems level analysis of high-throughput experimental data in human biology and medicinal chemistry.
The flagship product, MetaCore, is designed to assist scientists in drug target selection, validation, and identification of molecular biomarkers for disease states.
MetaCore is an integrated analytical suite with intuitive interface, data parsers and visualization tools and flexible network building algorithms working on the proprietary content of MetaBase - its manually curated database on human biology in norm and diseases.
The most comprehensive database in the field, MetaBase allows one to network over 90% of the known human proteins via physical protein-protein, protein-DNA and protein-compound interactions.
GeneGo's second product, MetaDrug, deals with prediction of human metabolism and toxicity of novel small molecules and compounds.
Customers include many of the largest pharmaceutical companies and leading university labs.
GeneGo was founded in 2000 by Tatiana Nikolskaya, then a wet lab molecular biologist at the University of Chicago.
GeneGo has business offices in San Diego, CA, Munich, Germany and a research facility in Moscow, Russia.
• Inforsense: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
